Related Articles
AURKA upregulation plays a role in fibroblast-reduced gefitinib sensitivity in the NSCLC cell line HCC827
Construction of a novel cell-based assay for the evaluation of anti-EGFR drug efficacy against EGFR mutation
A peptide antigen derived from EGFR T790M is immunogenic in non‑small cell lung cancer
Epidermal growth factor receptor mutation enhances expression of vascular endothelial growth factor in lung cancer
Shikonin sensitizes wild‑type EGFR NSCLC cells to erlotinib and gefitinib therapy